Please note the name of the medication has been removed as per TGA guidelines, and is referred to as ‘injection therapy’
The American Academy of Neurology has released an updated guideline, the first since 2008, based on a review of scientific studies of injection therapy as treatment for chronic migraine.
‘Injection therapy has been established as safe and effective for reducing the number of headaches in chronic migraine and should be offered as a treatment option to patients’ with this condition, ‘to increase the number of headache free days ‘. The therapy additionally ‘should be considered to reduce headache impact on health related quality of life’ in chronic migraine.
Note: Information on this site is not a substitute for professional medical advice.
References: Practice guideline update summary: Injection therapy for the treatment of blepharospasm, cervical dystonia, adult spasticity and headache, Simpson et al, Neurology 2016;86:1-9